Arrow Seldinger Arterial Catheterization Device Receives FDA Market Clearance

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration (FDA).

The new Arrow Seldinger Arterial Catheterization Device is indicated for short-term use. The device is designed to improve patient safety by eliminating confusion of catheter identification, reduce risk of complications associated with insertion technique, and provide optimal diagnostics leading to effective treatment for patients. Multiple sizes are available to provide customization to each patient, each insertion site, and each application.

“As we continue to discover new and innovative solutions, the Seldinger Arterial Catheterization Device is now part of our extensive arterial offering in the U.S. market,” said Jake Newman, Vice President and General Manager of Teleflex’s Vascular Access Division. “This innovative device is intended to facilitate ease of insertion and resistance to body collapse1.”

Teleflex expects to launch the Arrow® Seldinger Arterial Catheterization Device in the United States this year.

n our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

References:
1. Teleflex. Seldinger Arterial Catheter Benchtop Studies. Data on File, D011453: 2014.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.